资料单张
PRIMOBOLAN S TABLETS
SCHEDULING STATUS:
S5
PROPRIETARY NAME
(and dosage form):
PRIMOBOLAN S TABLETS
COMPOSITION
1 tablet Primobolan S contains
metenolone
acetate (17beta-hydroxy-1-methyl-5alpha-androst-1-en-3-one acetate) 25 mg.
PHARMACOLOGICAL CLASSIFICATION
A. 21.6 Anabolic steroids.
PHARMACOLOGICAL ACTION
In aplastic anaemias of various origins - both the idiopathic forms and those with exogenously damaged bone marrow -
high doses of metenolone acetate may stimulate bone marrow function, particularly erythropoiesis. Metenolone acetate is
a non-17alpha-alkylated anabolic steroid.
INDICATIONS
Aplastic anaemias.
CONTRA-INDICATIONS
Primobolan S is contra-indicated in pregnancy as the metenolone acetate contained in the preparation, like all anabolic
agents, possesses some androgenic activity which may lead to signs of virilisation in the female newborn.
Because of this androgenic activity, Primobolan S is also contra-indicated in patients with prostatic carcinoma, since
such substances may aggravate the disease.
DOSAGE AND DIRECTIONS FOR USE
The therapy may have to be continued for at least 3 months at a dosage of 2-3 mg/kg bodyweight per day, ie 4-6 tablets
for a person weighing 50 kg. Since some patients only respond after several months, treatment must not be stopped too
soon. After improvement of the clinical picture treatment should, as a general rule, be continued for a further few weeks.
Deterioration of the blood count after discontinuation of therapy may be reversed by renewed administration of
Primobolan S.
SIDE EFFECTS AND SPECIAL PRECAUTIONS
In female patients, signs of virilisation (acne, hirsutism, hoarseness, possibly irreversible deepening of the voice) must be
reckoned with; in sexually mature women menstrual irregularities may occur.
In adult males, spermatogenesis may be
阅读完整的文件
资料单张 